New schizophrenia treatment shows promise in major trial
NCT ID NCT02282761
Summary
This study tested whether a medication called ITI-007 could help control symptoms in people experiencing a schizophrenia flare-up. Researchers compared the drug against a placebo in 450 adults with schizophrenia over 28 days. They measured changes in symptoms like hallucinations, delusions, and emotional withdrawal to see if the medication was effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Little Rock, Arkansas, United States
-
Clinical Site
Springdale, Arkansas, United States
-
Clinical Site
Escondido, California, United States
-
Clinical Site
Garden Grove, California, United States
-
Clinical Site
Long Beach, California, United States
-
Clinical Site
San Diego, California, United States
-
Clinical Site
Fort Lauderdale, Florida, United States
-
Clinical Site
Rockville, Maryland, United States
-
Clinical Site
St Louis, Missouri, United States
-
Clinical Site
Marlton, New Jersey, United States
-
Clinical Site
Austin, Texas, United States
Conditions
Explore the condition pages connected to this study.